CD14 receptor gene promoter polymorphism: Awakening maternal immunity during pregnancy
- Authors
- Lim, J. E.; Kim, T.; Lee, N. W.; Oh, M. J.; Seol, H. J.; Min, J. Y.; Kim, H. J.
- Issue Date
- Mar-2006
- Publisher
- SAGE PUBLICATIONS LTD
- Keywords
- pre-eclampsia; pregnant women; immune system; monocyte; CD14 receptor; polymorphism
- Citation
- JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, v.34, no.2, pp 176 - 182
- Pages
- 7
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Volume
- 34
- Number
- 2
- Start Page
- 176
- End Page
- 182
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/18983
- DOI
- 10.1177/147323000603400207
- ISSN
- 0300-0605
1473-2300
- Abstract
- We investigated whether monocyte CD14 receptor gene promoter polymorphisms were associated with the development and severity of pre-eclampsia. We genotyped the CD14-260 C/T polymorphism in 36 pre-eclamptic patients and 52 healthy pregnant controls. A total of 30.6% and 69.4% of pre-eclamptic patients had the C and T alleles, respectively, and 48.0% and 52.0% of the controls, respectively. More pre-eclamptic patients were TT homozygotes compared with controls (50.0% versus 13.5%). In pre-eclamptic patients, the TT homozygotes exhibited a significantly higher mean systolic blood pressure compared with the non-TT homozygotes (173 +/- 28 mmHg versus 153 +/- 22 mmHg). We also noted a tendency towards increased proteinuria and placental abruption in the TT homozygotes compared with the non-TT homozygotes. We conclude that CD14 gene promoter polymorphisms appear to be a risk factor for pre-eclampsia. With further research, these findings might form the basis of a prognostic tool for pre-eclampsia.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Obstetrics and Gynecology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.